DK3117012T3 - Fremgangsmåder til overvågning af immunosuppressive terapier hos en transplantmodtager - Google Patents

Fremgangsmåder til overvågning af immunosuppressive terapier hos en transplantmodtager Download PDF

Info

Publication number
DK3117012T3
DK3117012T3 DK15761889.3T DK15761889T DK3117012T3 DK 3117012 T3 DK3117012 T3 DK 3117012T3 DK 15761889 T DK15761889 T DK 15761889T DK 3117012 T3 DK3117012 T3 DK 3117012T3
Authority
DK
Denmark
Prior art keywords
methods
transplant recipient
immunosuppressive therapies
monitoring
monitoring immunosuppressive
Prior art date
Application number
DK15761889.3T
Other languages
English (en)
Other versions
DK3117012T4 (da
Inventor
Robert Woodward
Marica Grskovic
Jim Yee
Mitch Nelles
David Hiller
Original Assignee
Caredx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54072508&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3117012(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Caredx Inc filed Critical Caredx Inc
Application granted granted Critical
Publication of DK3117012T3 publication Critical patent/DK3117012T3/da
Publication of DK3117012T4 publication Critical patent/DK3117012T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK15761889.3T 2014-03-14 2015-03-13 Fremgangsmåder til overvågning af immunsuppressive behandlinger hos en transplantationsmodtager DK3117012T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461953582P 2014-03-14 2014-03-14
PCT/US2015/020603 WO2015138997A1 (en) 2014-03-14 2015-03-13 Methods of monitoring immunosuppressive therapies in a transplant recipient

Publications (2)

Publication Number Publication Date
DK3117012T3 true DK3117012T3 (da) 2019-05-13
DK3117012T4 DK3117012T4 (da) 2026-02-09

Family

ID=54072508

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15761889.3T DK3117012T4 (da) 2014-03-14 2015-03-13 Fremgangsmåder til overvågning af immunsuppressive behandlinger hos en transplantationsmodtager

Country Status (16)

Country Link
US (11) US11767559B2 (da)
EP (1) EP3117012B2 (da)
CN (2) CN113528645A (da)
AU (3) AU2015229083B2 (da)
BR (1) BR112016021038B1 (da)
CA (1) CA2970916C (da)
DK (1) DK3117012T4 (da)
ES (1) ES2726650T5 (da)
FI (1) FI3117012T4 (da)
HR (1) HRP20190759T1 (da)
HU (1) HUE043288T2 (da)
PL (1) PL3117012T5 (da)
PT (1) PT3117012T (da)
SI (1) SI3117012T1 (da)
TR (1) TR201907106T4 (da)
WO (1) WO2015138997A1 (da)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US20120185176A1 (en) 2009-09-30 2012-07-19 Natera, Inc. Methods for Non-Invasive Prenatal Ploidy Calling
EP2572003A4 (en) 2010-05-18 2016-01-13 Natera Inc METHOD FOR NONINVASIVE PRANATAL PLOIDIE ASSIGNMENT
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190284623A1 (en) * 2010-05-18 2019-09-19 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) * 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332785B2 (en) * 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
WO2012088456A2 (en) 2010-12-22 2012-06-28 Natera, Inc. Methods for non-invasive prenatal paternity testing
AU2011358564B9 (en) 2011-02-09 2017-07-13 Natera, Inc Methods for non-invasive prenatal ploidy calling
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
DK3004388T4 (da) 2013-05-29 2023-08-28 Chronix Biomedical Påvisning og kvantificering af cellefrit dna fra donor i kredsløbet hos organtransplantatmodtagere
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
CA2970916C (en) 2014-03-14 2025-02-04 Caredx, Inc. METHODS FOR MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
EP3957749A1 (en) 2014-04-21 2022-02-23 Natera, Inc. Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
EP3164503B1 (en) 2014-07-03 2024-08-28 Agilent Technologies, Inc. Methods for non-invasive detection of transplant health or rejection
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
CN106544407B (zh) * 2015-09-18 2019-11-08 广州华大基因医学检验所有限公司 确定受体cfDNA样本中供体来源cfDNA比例的方法
CN105483123B (zh) * 2015-11-23 2019-02-22 元码基因科技（北京）股份有限公司 遗传标记组合、个体基因身份证及其用途
WO2017181202A2 (en) 2016-04-15 2017-10-19 Natera, Inc. Methods for lung cancer detection
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
CN110114477A (zh) * 2016-11-02 2019-08-09 威斯康星州立大学医学院 用于使用总的和特异性无细胞dna评估风险的方法
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
CN106520982B (zh) * 2016-12-05 2019-11-08 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于身份鉴定的复合分型系统
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CN107058562B (zh) * 2017-05-17 2018-04-10 成都仕康美生物科技有限公司 Snp位点的应用及其检测试剂盒
AU2018288832B2 (en) 2017-06-20 2025-03-06 The Medical College Of Wisconsin, Inc. Assessing transplant complication risk with total cell-free DNA
CA3067635A1 (en) * 2017-06-20 2018-12-27 The Medical College Of Wisconsin, Inc. Transplant patient monitoring with cell-free dna
JP2021506342A (ja) 2017-12-14 2021-02-22 ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． 移植のための移植片適合性の評価
SG11202005474RA (en) * 2017-12-15 2020-07-29 Acrannolife Genomics Pvt Ltd A non-invasive method for monitoring transplanted organ status in organ-transplant recipients
CN107937571B (zh) * 2018-01-16 2021-12-07 良培基因生物科技（武汉）有限公司 一种基于信息snp集及其引物的核酸质谱亲权鉴定方法
EP3517629A1 (en) 2018-01-30 2019-07-31 Myway Genetics S.r.L. Use of cfdna fragments as biomarkers in patients after organ transplantation
US12398389B2 (en) 2018-02-15 2025-08-26 Natera, Inc. Methods for isolating nucleic acids with size selection
CA3090426A1 (en) 2018-04-14 2019-10-17 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
WO2020010255A1 (en) * 2018-07-03 2020-01-09 Natera, Inc. Methods for detection of donor-derived cell-free dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US20210301342A1 (en) * 2018-09-07 2021-09-30 Sequenom, Inc. Methods, and systems to detect transplant rejection
US20200109449A1 (en) * 2018-10-09 2020-04-09 Tai Diagnostics, Inc. Cell lysis assay for cell-free dna analysis
US20220073989A1 (en) * 2018-12-20 2022-03-10 The Regents Of The University Of California Optimizing Detection of Transplant Injury by Donor-Derived Cell-Free DNA
EP3927845A1 (en) * 2019-02-19 2021-12-29 Sequenom, Inc. Compositions, methods, and systems to detect hematopoietic stem cell transplantation status
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
EP3980559A1 (en) 2019-06-06 2022-04-13 Natera, Inc. Methods for detecting immune cell dna and monitoring immune system
EP4106872A4 (en) * 2020-03-06 2024-04-10 Denovo Biopharma LLC Compositions and methods for assessing the efficacy of inhibitors of neurotransmitter transporters
EP4168586A1 (en) * 2020-06-19 2023-04-26 CareDx, Inc. Methods for monitoring allogeneic cells
CN113061666A (zh) * 2020-12-30 2021-07-02 中南大学湘雅二医院 肝移植后巨细胞病毒的检测方法、应用及系统
WO2022232609A1 (en) * 2021-04-30 2022-11-03 Caredx, Inc. Methods for detecting, monitoring, and guiding treatment of allograft rejection using discriminating gene expression signatures
EP4373961A4 (en) * 2021-07-23 2025-08-06 Univ Georgetown USE OF GENETIC AND EPIGENETIC MARKERS TO DETECT CELL DEATH
US20230338419A1 (en) * 2022-03-21 2023-10-26 The Trustees Of The University Of Pennsylvania Methods and apparatus for diagnosis and detection of cardiac allograft vasculopathy
AU2023237885A1 (en) * 2022-03-21 2024-09-12 Caredx, Inc. Methods for non-invasively monitoring organ health in cross-species transplantation

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6401267B1 (en) 1993-09-27 2002-06-11 Radoje Drmanac Methods and compositions for efficient nucleic acid sequencing
USRE39920E1 (en) * 1997-05-30 2007-11-13 Xenomics, Inc. Methods for detection of nucleic acid sequences in urine
US6132997A (en) 1999-05-28 2000-10-17 Agilent Technologies Method for linear mRNA amplification
US7403972B1 (en) 2002-04-24 2008-07-22 Ip Venture, Inc. Method and system for enhanced messaging
EP1377686A4 (en) 2001-04-12 2007-07-25 Caliper Life Sciences Inc SYSTEMS AND METHOD FOR GENETIC ANALYSIS WITH HIGH THROUGHPUT
US6977162B2 (en) 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
WO2005035725A2 (en) 2003-10-08 2005-04-21 The Trustees Of Boston University Methods for prenatal diagnosis of chromosomal abnormalities
US7149658B2 (en) 2004-02-02 2006-12-12 United Parcel Service Of America, Inc. Systems and methods for transporting a product using an environmental sensor
US20060228721A1 (en) 2005-04-12 2006-10-12 Leamon John H Methods for determining sequence variants using ultra-deep sequencing
EP2007909A4 (en) 2006-04-07 2011-01-26 Xdx Inc EXPRESSION OF NUCLEIC ACID IN RESPONSE TO STEROIDS AND PREDICTION OF DISEASE ACTIVITY
US9370689B2 (en) 2008-01-07 2016-06-21 The Quantum Group, Inc. System and methods for providing dynamic integrated wellness assessment
ES2595489T3 (es) 2008-07-18 2016-12-30 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR
CN104195227B (zh) * 2008-11-07 2017-04-12 适应生物技术公司 通过序列分析监测状况的方法
HUE052213T2 (hu) * 2009-11-06 2021-04-28 Univ Leland Stanford Junior Grafitkilökõdés nem invazív diagnosztizálása szervátültetett betegekben
US20110173023A1 (en) 2010-01-12 2011-07-14 Gryphes Inc. Method and System for Managing Organ Transplant Transporation
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US20180344215A1 (en) 2015-11-24 2018-12-06 Dacadoo Ag Automated health data acquisition, processing and communication system and method
US10131947B2 (en) * 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
CN102618626B (zh) * 2011-01-30 2014-05-14 杭州优思达生物技术有限公司 一种快速单核苷酸多态性的检测方法及试剂盒
US20130024127A1 (en) 2011-07-19 2013-01-24 John Stuelpnagel Determination of source contributions using binomial probability calculations
EP2758538B1 (en) * 2011-09-22 2018-10-31 Lineage Biosciences, Inc. Methods for analyzing heterogeneous samples
WO2013049892A1 (en) 2011-10-07 2013-04-11 Murdoch Childrens Research Institute Diagnostic assay for tissue transplantation status
US8977373B2 (en) 2011-12-28 2015-03-10 Caterpillar Inc. Systems and methods for extending physical sensor range using virtual sensors
CN103374518B (zh) * 2012-04-12 2018-03-27 维里纳塔健康公司 拷贝数变异的检测和分类
AU2013249012B2 (en) 2012-04-19 2019-03-28 The Medical College Of Wisconsin, Inc. Highly sensitive surveillance using detection of cell free DNA
US20150154352A1 (en) 2012-06-21 2015-06-04 Gigagen, Inc. System and Methods for Genetic Analysis of Mixed Cell Populations
US20150203916A1 (en) 2012-06-27 2015-07-23 Music Foundation For Research Development Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm
US20140088995A1 (en) 2012-09-21 2014-03-27 Md Revolution, Inc. Systems and methods for dynamic adjustments for personalized health and wellness programs
WO2014074501A1 (en) 2012-11-06 2014-05-15 Quest Diagnostics Investments Incorporated Molecular markers for diagnosis of acute cellular rejection and acute tubular necrosis
WO2014116729A2 (en) 2013-01-22 2014-07-31 The Board Of Trustees Of The Leland Stanford Junior University Haplotying of hla loci with ultra-deep shotgun sequencing
DK3004388T4 (da) 2013-05-29 2023-08-28 Chronix Biomedical Påvisning og kvantificering af cellefrit dna fra donor i kredsløbet hos organtransplantatmodtagere
WO2015069933A1 (en) 2013-11-06 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Circulating cell-free dna for diagnosis of transplant rejection
US9982301B2 (en) 2014-01-07 2018-05-29 Cornell University Urine mRNA profile and acute dysfunction of kidney allograft
CA2970916C (en) * 2014-03-14 2025-02-04 Caredx, Inc. METHODS FOR MONITORING IMMUNOSUPPRESSIVE THERAPIES IN A TRANSPLANT RECIPIENT
CA2956925C (en) 2014-08-01 2024-02-13 Dovetail Genomics, Llc Tagging nucleic acids for sequence assembly
US9648446B2 (en) 2015-09-22 2017-05-09 Veniam, Inc. Systems and methods for shipping management in a network of moving things
WO2018000031A1 (en) 2016-06-27 2018-01-04 Olivia Newton-John Cancer Research Institute Use of cell free dna as a measure of organ health following transplantation
US10602964B2 (en) 2016-08-17 2020-03-31 Koninklijke Philips N.V. Location, activity, and health compliance monitoring using multidimensional context analysis
CN110352251A (zh) * 2017-03-08 2019-10-18 豪夫迈·罗氏有限公司 引物延伸靶标富集及对其的包括同时富集dna和rna的改进
JP2020515278A (ja) 2017-04-04 2020-05-28 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ドナー遺伝子型の非存在下での移植由来循環セルフリーｄｎａの定量化
JP7009518B2 (ja) 2017-06-20 2022-01-25 イルミナ インコーポレイテッド 既知又は未知の遺伝子型の複数のコントリビューターからのｄｎａ混合物の分解及び定量化のための方法並びにシステム
IL271147B2 (en) 2017-06-20 2025-04-01 Illumina Inc Accurate computational methods for decomposing mixtures of DNA from donors with unknown genotypes
SG11202005474RA (en) 2017-12-15 2020-07-29 Acrannolife Genomics Pvt Ltd A non-invasive method for monitoring transplanted organ status in organ-transplant recipients
US11961033B2 (en) 2018-01-05 2024-04-16 Convey, Llc System and method for dynamically scheduling API-based shipment updates across carriers
MX2020007666A (es) 2018-01-19 2020-10-14 Univ Maryland Técnicas para la manipulación de órganos humanos durante el transporte.
CN112118781B (zh) 2018-03-12 2026-02-27 加利福尼亚大学董事会 通过t细胞受体亚基库多样性的分析评估移植排斥状态
EP3790987A4 (en) 2018-05-10 2022-01-19 The Scripps Research Institute GENOME-WIDE CLASSIFIERS FOR THE DETECTION OF SUBACUTE TRANSPLANT REJECTION AND OTHER TRANSPLANT CONDITIONS
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
WO2020010255A1 (en) * 2018-07-03 2020-01-09 Natera, Inc. Methods for detection of donor-derived cell-free dna
US10402774B1 (en) 2018-07-25 2019-09-03 Capital One Services, LLP Intelligence platform for automated retrieval or protection of a package or a person by an unmanned vehicle (UV)
US20210301342A1 (en) * 2018-09-07 2021-09-30 Sequenom, Inc. Methods, and systems to detect transplant rejection
US20220073989A1 (en) * 2018-12-20 2022-03-10 The Regents Of The University Of California Optimizing Detection of Transplant Injury by Donor-Derived Cell-Free DNA
EP3927845A1 (en) 2019-02-19 2021-12-29 Sequenom, Inc. Compositions, methods, and systems to detect hematopoietic stem cell transplantation status
EP3712898A1 (en) 2019-03-21 2020-09-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Method of predicting whether a kidney transplant recipient is at risk of having allograft loss
WO2021021657A1 (en) 2019-07-29 2021-02-04 University Of Miami System and method for ai-based eye condition determinations
WO2021092476A1 (en) 2019-11-06 2021-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for analyzing nucleic acid molecules
EP4168586A1 (en) 2020-06-19 2023-04-26 CareDx, Inc. Methods for monitoring allogeneic cells
WO2022035519A1 (en) 2020-08-14 2022-02-17 Caredx, Inc. A system and methods for determining scores indicative of a transplant recipient's activities and behaviors

Also Published As

Publication number Publication date
EP3117012B2 (en) 2025-11-26
EP3117012A1 (en) 2017-01-18
HUE043288T2 (hu) 2019-08-28
US20230407394A1 (en) 2023-12-21
AU2015229083A1 (en) 2016-09-08
HRP20190759T1 (hr) 2019-06-14
AU2023208145A1 (en) 2023-08-17
PL3117012T5 (pl) 2026-03-16
CA2970916A1 (en) 2015-09-17
US20230399695A1 (en) 2023-12-14
US20230407396A1 (en) 2023-12-21
SI3117012T1 (sl) 2019-07-31
PL3117012T3 (pl) 2019-08-30
CA2970916C (en) 2025-02-04
BR112016021038B1 (pt) 2023-12-12
TR201907106T4 (tr) 2019-06-21
EP3117012A4 (en) 2017-08-30
US12404547B1 (en) 2025-09-02
DK3117012T4 (da) 2026-02-09
US20250354207A1 (en) 2025-11-20
CN113528645A (zh) 2021-10-22
CN106536752B (zh) 2021-08-06
US20230399694A1 (en) 2023-12-14
AU2015229083B2 (en) 2021-06-17
US20160145682A1 (en) 2016-05-26
ES2726650T3 (es) 2019-10-08
US20230407392A1 (en) 2023-12-21
AU2021204489A1 (en) 2021-07-29
AU2021204489B2 (en) 2023-04-27
BR112016021038A2 (pt) 2017-08-15
AU2023208145B2 (en) 2025-08-21
WO2015138997A1 (en) 2015-09-17
ES2726650T5 (en) 2026-04-14
FI3117012T4 (fi) 2026-02-25
US11767559B2 (en) 2023-09-26
US20230407395A1 (en) 2023-12-21
CN106536752A (zh) 2017-03-22
US20230399696A1 (en) 2023-12-14
PT3117012T (pt) 2019-05-30
US20230407393A1 (en) 2023-12-21
EP3117012B1 (en) 2019-02-20

Similar Documents

Publication Publication Date Title
DK3117012T3 (da) Fremgangsmåder til overvågning af immunosuppressive terapier hos en transplantmodtager
DK3224648T3 (da) System til monitorering af et maritimt miljø
DK3186376T3 (da) Fremgangsmåder til forbedring af cas9-medieret manipulationseffektivitet
DK3278041T3 (da) Automatiseret kryogent opbevaringssystem
DK3105252T3 (da) Bispecifikke antistoffer til anvendelse ved stamcelletransplantation
DK3113883T3 (da) Cellesorteringssystem der anvender mikrofremstillede komponenter
DK3207481T3 (da) Reduktion af fejl ved forudsigelse af genetiske slægtskab
DK3198026T3 (da) Fremgangsmåde til bestemmelse af pik3ca-mutationsstatus i en prøve
DK3122444T3 (da) Fremgangsmåde til fremstilling af membraner
IL274458A (en) Ultra-high density cell banking methods
DK3196572T3 (da) Køleindretning til container
DK3345687T3 (da) Mobilt system til rengøring af en beholder
IL257678A (en) Methods of stem cell transplantation
DK2983680T3 (da) Forbedring af organer til transplantation
DK3365436T3 (da) Fremgangsmåder til fremstilling af en primær celleprøve
DK3105873T3 (da) Teknik til lagring af softbits
PL3206724T3 (pl) Pojemnik do preparowania próbek
DK3190875T3 (da) Fremgangsmåder og systemer til udklækning af æg
SG11201610359QA (en) Method for determining a protein-protein interaction
DK2942098T3 (da) Forbedret fremgangsmåde til fjernelse af nitrit
DK3230013T3 (da) Kuffert til opbevaring af værktøjer eller smådele
DK3028646T3 (da) Foldelig indretning til opsamling af en afføringsprøve
DK3446866T3 (da) Maskine til fremstilling af beholdere
DK3163041T3 (da) Indretning til rensning af udstødning
FI20145326A7 (fi) Menetelmä nosturin kääntöajamiseksi